{"cik":2104204,"taxonomy":"us-gaap","tag":"EarningsPerShareBasic","label":"Earnings Per Share, Basic","description":"The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.","entityName":"Alamar Biosciences, Inc.","units":{"USD/shares":[{"start":"2025-01-01","end":"2025-03-31","val":-0.68,"accn":"0001193125-26-213424","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-08","frame":"CY2025Q1"},{"start":"2025-01-01","end":"2025-06-30","val":-1.3,"accn":"0001193125-26-343003","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-11"},{"start":"2025-04-01","end":"2025-06-30","val":-0.62,"accn":"0001193125-26-343003","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-11","frame":"CY2025Q2"},{"start":"2026-01-01","end":"2026-03-31","val":-1.74,"accn":"0001193125-26-213424","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-08","frame":"CY2026Q1"},{"start":"2026-01-01","end":"2026-06-30","val":-0.97,"accn":"0001193125-26-343003","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-11"},{"start":"2026-04-01","end":"2026-06-30","val":-0.22,"accn":"0001193125-26-343003","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-11","frame":"CY2026Q2"}]}}